Princeton Global Asset Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Princeton Global Asset Management’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-100	Closed	-$37	–	613
2023 Q2	$37	Hold	100	–	–	﹤0.01%	580
2023 Q1	$33	Hold	100	–	–	﹤0.01%	586
2022 Q4	$0	Hold	100	–	–	﹤0.01%	598
2022 Q3	$0	Hold	100	–	–	﹤0.01%	578
2022 Q2	$0	Hold	100	–	–	﹤0.01%	610
2022 Q1	$0	Buy	+100	New	+$163	﹤0.01%	614

Princeton Global Asset Management's BLCM Position: Q3 2023 in Review

Princeton Global Asset Management sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q3 2023, closing a stake of 100 shares — an estimated $37 sold.

Princeton Global Asset Management first reported a position in BLCM in Q1 2022 and held it in 6 quarters. The position peaked at $37 in Q2 2023. 0 funds tracked by Wall St. Rank hold BLCM as of Q3 2023.

Princeton Global Asset Management reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Princeton Global Asset Management sold 100 Bellicum Pharmaceuticals, Inc. shares in Q3 2023, an estimated $37.
Princeton Global Asset Management first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2022 and held it in 6 quarters.
Princeton Global Asset Management's Bellicum Pharmaceuticals, Inc. position peaked at $37 in Q2 2023.
0 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q3 2023.

Based on Princeton Global Asset Management's 13F filing for Q3 2023, filed 27 Oct 2023.